D05 fundamentals
An in-depth look to DECIPHERA PHARMACEUTICALS INC operating, investing, and financing activities
D05 free cash flow for Q1 24 is -50.72 M EUR. For 2023, D05 free cash flow was -133.61 M EUR and operating cash flow was -132.91 M EUR.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM